Skip to main content
. Author manuscript; available in PMC: 2012 Jul 20.
Published in final edited form as: J Immunol. 2007 Oct 1;179(7):4732–4740. doi: 10.4049/jimmunol.179.7.4732

Table II.

Summary of SIV Gag peptide specific CD8+ T cell responses (frequency of the responding cells) after i.v. SIVmac239 challenge

Functional Profilea Apoptotic Signalsa


Animal Weeks PC IL-2 (%) TNF-α (%) IFN-γ (%) CD107ab (%) Bcl-2 (%) Caspase-3 (%)
34569 Pb 4 0.14 c 0.23 0.13 1.1 −0.9d
7 0.27 0.79 0.48 0.05 3.7 0.25
12 b 0.23 0.3 c 2.5 3.1
32212 P 4 0.17 b 0.08 0.4 4.1 −0.5d
7 0.12 0.40 0.43 1.11 5.1 −1.54d
12 0.4 0.37 0.3 1.87 3.8 1.5
32273 Ue 4 c c 0.08 c 0.4 6.9
7 c c c 1.02 2.0 2.0
12 0.4 1.73 1.67 0.81 −1.4d 16.7
30706 Ue 4 ND ND ND ND ND ND
7 0.29 0.17 0.20 1.25 2.1 0.1
12 c c 0.06 c 1.5 4.1
a

Data show the maximum value at 0.1 or 1 µg/ml peptide.

b

Protected.

c

Values less than the cutoff (<0.05%).

d

Negative net change (value in the DMSO control was higher than in the peptide stimulated sample).

e

Unprotected.